Abstract
In The Pune Maternal Nutrition Study, vitamin B12 deficiency was seen in 65% of pregnant women, folate deficiency was rare. Maternal total homocysteine concentrations were inversely associated with offspring birthweight, and low vitamin B12 and high folate concentrations predicted higher offspring adiposity and insulin resistance. These findings guided a nested pre-conceptional randomized controlled trial ‘Pune Rural Intervention in Young Adolescents (PRIYA)’. The interventions included: 1) vitamin B12+multi-micronutrients the United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP) and proteins (B12+MMN), 2) vitamin B12 (B12 alone), and 3) placebo. Intervention improved maternal pre-conceptional and in-pregnancy micronutrient nutrition. Gene expression analysis in cord blood mononuclear cells in 88 pregnancies revealed 75 differentially expressed genes between the B12+MMN and placebo groups. The enriched biological processes included G2/M phase transition, chromosome segregation, and nuclear division. Enriched pathways included, mitotic spindle checkpoint and DNA damage response while enriched human phenotypes were sloping forehead and decreased head circumference. Fructose-bisphosphatase 2 (FBP2) and Cell Division Cycle Associated 2 (CDCA2) genes were under-expressed in the B12 alone group. The latter, involved in chromosome segregation was under-expressed in both intervention groups. Based on the role of B-complex vitamins in the synthesis of nucleotides and S-Adenosyl Methionine, and the roles of vitamins A and D on gene expression, we propose that the multi-micronutrient intervention epigenetically affected cell cycle dynamics. Neonates in the B12+MMN group had the highest ponderal index. Follow up studies will reveal if the intervention and the altered biological processes influence offspring diabesity.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
CTRI (2012/12/003212) and ISRCTN (32921044)
Funding Statement
The work was supported by research grants from Department of Biotechnology (DBT), Government of India (CEIB-BT/PR12629/MED/97/364/2016) and Indian Council of Medical Research (ICMR) - Medical Research Council (MRC), UK grant (No.58/1/8/ICMR-MRC/2009-NCD-II).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The PRIYA trial was approved by the KEM Hospital Research Centre Ethics committee and monitored by a Data Safety Monitoring Board (DSMB) and a Scientific Advisory Committee (SAC). Informed consent was signed by parents all participants, and an informed assent was signed by participants below 18 years of age. After attaining 18 years of age, all participants signed their own informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Added 'Funding' and 'Data availability' sections. Provided data link on the portal. Added 'Ethics permissions and Trial registration', 'Participants', 'Interventions and comparators', 'Outcomes', and 'RNA sequencing and data analysis' as separate sections to methodology. Table 1 split into two tables. Figure 4 added. Changed citation style. Other than these, many changes in figures, tables, and text.
Data Availability
The datasets generated for this study can be found in NCBI SRA: PRJNA756634.
